Abstract:
A method for quickly assaying the cAMP content or the adenylate cyclase activity in a biological sample containing endogenous non-cyclic adenine nucleotides without resort to any radioactive reagents. More particularly, a method for assaying the cAMP content or the adenylate cyclase activity in a biological sample containing endogenous non-cyclic adenine nucleotides selected from the group consisting of cAMP formed by endogenous adenylate cyclase, ATP, AMP, ADP and mixtures thereof which comprises: (1) adding efficacious amounts of apyrase, adenosine deaminase and alkaline phosphatase to the above sample to thereby enzymatically remove the endogenous non-cyclic adenine nucleotides other than cAMP and glycose-6-phosphate therefrom; (2) enzymatically converting cAMP into AMP; and (3) thus quantitating AMP without resort to any radioactive substances; and a kit for performing this method.
Abstract:
A method for quickly assaying the cAMP content or the adenylate cyclase activity in a biological sample containing endogenous non-cyclic adenine nucleotides without resort to any radioactive reagents. More particularly, a method for assaying the cAMP content or the adenylate cyclase activity in a biological sample containing endogenous non-cyclic adenine nucleotides selected from the group consisting of cAMP formed by endogenous adenylate cyclase, ATP, AMP, ADP and mixtures thereof which comprises: (1) adding efficacious amounts of apyrase, adenosine deaminase and alkaline phosphatase to the above sample to thereby enzymatically remove the endogenous non-cycli c adenine nucleotides other than cAMP and glycose-6-phosphate therefrom; (2) enzymatically converting cAMP into AMP; and (3) thus quantitating AMP withou t resort to any radioactive substances; and a kit for performing this method.
Abstract:
The present invention relates to a method for quickly determining cAMP content or an adenylate cyclase activity in a biological sample containing non-cyclic adenine nucleotides without the use of radioactive agents. Particularly, the present invention provides a method of determining cAMP content or an adenylate cyclase activity in a biological sample containing non-cyclic adenine nucleotides selected from the group consisting of cAMP produced by endogenous adenylate cyclase, and AMP, ATP, ADP and a mixture thereof, which comprises (1) combining a biological sample with effective amounts of apyrase, adenosine deaminase and alkaline phosphatase to enzymatically remove non-cyclic adenine nucleotides other than cAMP, and glucose-6-phosphate in the sample; (2) enzymatically converting cAMP into AMP; (3) determining an amount of AMP without the use of radioactive agents, and a kit to carry out the method.
Abstract:
Un método para eliminar los nucleótidos de adenina no cíclicos, componiéndose de ATP, ADP y AMP endógenos, y la glucosa-6-fosfato endógena en una muestra biológica, el cual comprende el tratar dicha muestra con cantidades eficaces de apirasa, fosfatasa alcalina y adenosina desaminasa, con exclusión de la 5¿-nucleotidasa, para eliminar dichos nucleótidos de adenina no cíclicos y la glucosa-6-fosfato.
Abstract:
The present invention relates to a method for quickly determining cAMP content or an adenylate cyclase activity in a biological sample containing non-cyclic adenine nucleotides without the use of radioactive agents. Particularly, the present invention provides a method of determining cAMP content or an adenylate cyclase activity in a biological sample containing non-cyclic adenine nucleotides selected from the group consisting of cAMP produced by endogenous adenylate cyclase, and AMP, ATP, ADP and a mixture thereof, which comprises (1) combining a biological sample with effective amounts of apyrase, adenosine deaminase and alkaline phosphatase to enzymatically remove non-cyclic adenine nucleotides other than cAMP, and glucose-6-phosphate in the sample; (2) enzymatically converting cAMP into AMP; (3) determining an amount of AMP without the use of radioactive agents, and a kit to carry out the method.
Abstract:
The present invention relates to a method for quickly determining cAMP content or an adenylate cyclase activity in a biological sample containing non-cyclic adenine nucleotides without the use of radioactive agents. Particularly, the present invention provides a method of determining cAMP content or an adenylate cyclase activity in a biological sample containing non-cyclic adenine nucleotides selected from the group consisting of cAMP produced by endogenous adenylate cyclase, and AMP, ATP, ADP and a mixture thereof, which comprises (1) combining a biological sample with effective amounts of apyrase, adenosine deaminase and alkaline phosphatase to enzymatically remove non-cyclic adenine nucleotides other than cAMP, and glucose-6-phosphate in the sample; (2) enzymatically converting cAMP into AMP; (3) determining an amount of AMP without the use of radioactive agents, and a kit to carry out the method.
Abstract:
The present invention relates to a method for quickly determining cAMP content or an adenylate cyclase activity in a biological sample containing non-cyclic adenine nucleotides without the use of radioactive agents. Particularly, the present invention provides a method of determining cAMP content or an adenylate cyclase activity in a biological sample containing non-cyclic adenine nucleotides selected from the group consisting of cAMP produced by endogenous adenylate cyclase, and AMP, ATP, ADP and a mixture thereof, which comprises (1) combining a biological sample with effective amounts of apyrase, adenosine deaminase and alkaline phosphatase to enzymatically remove non-cyclic adenine nucleotides other than cAMP, and glucose-6-phosphate in the sample; (2) enzymatically converting cAMP into AMP; (3) determining an amount of AMP without the use of radioactive agents, and a kit to carry out the method.
Abstract:
The present invention relates to a method for quickly determining cAMP content or an adenylate cyclase activity in a biological sample containing non-cyclic adenine nucleotides without the use of radioactive agents. Particularly, the present invention provides a method of determining cAMP content or an adenylate cyclase activity in a biological sample containing non-cyclic adenine nucleotides selected from the group consisting of cAMP produced by endogenous adenylate cyclase, and AMP, ATP, ADP and a mixture thereof, which comprises (1) combining a biological sample with effective amounts of apyrase, adenosine deaminase and alkaline phosphatase to enzymatically remove non-cyclic adenine nucleotides other than cAMP, and glucose-6-phosphate in the sample; (2) enzymatically converting cAMP into AMP; (3) determining an amount of AMP without the use of radioactive agents, and a kit to carry out the method.
Abstract:
The present invention relates to a method for quickly determining cAMP content or an adenylate cyclase activity in a biological sample containing non-cyclic adenine nucleotides without the use of radioactive agents. Particularly, the present invention provides a method of determining cAMP content or an adenylate cyclase activity in a biological sample containing non-cyclic adenine nucleotides selected from the group consisting of cAMP produced by endogenous adenylate cyclase, and AMP, ATP, ADP and a mixture thereof, which comprises (1) combining a biological sample with effective amounts of apyrase, adenosine deaminase and alkaline phosphatase to enzymatically remove non-cyclic adenine nucleotides other than cAMP, and glucose-6-phosphate in the sample; (2) enzymatically converting cAMP into AMP; (3) determining an amount of AMP without the use of radioactive agents, and a kit to carry out the method.
Abstract:
PROBLEM TO BE SOLVED: To measure cAMP without using a radioactive reagent by treating a biological sample with apyrase, alkali phosphatase, adenosine deaminase, enzymatically converting cAMP to AMP and detecting the produced AMP. SOLUTION: In this method for measuring cAMP amount or adenylate cyclase activity in a biological sample, the biological sample is treated with apyrase, alkaliphosphatase and adenosine deaminase in an amount which is effective for removing noncyclic adenine nucleotides comprising endogenic ATP, ADP and AMP, and glucose-6-phosphoric acid and cAMP in the biological sample is. enzymatically converted to AMP and then, the produced AMP amount is measured without using a radioactive reagent to rapidly measure adenylate cyclase activity capable of measuring cAMP mediating hyperglycemic action of adrenaline and glucagon in liver and change of an amount of the cAMP.